MammoSite® radiation therapy system

Oscar E. Streeter; Frank A. Vicini; Martin Keisch; Melvin A. Astrahan; Gabor Jozsef; Melvin Silverstein; Howard Silberman; Deirdre Cohen; Kristin A. Skinner

doi:10.1016/S0960-9776(03)00157-7

MammoSite® radiation therapy system

Oscar E. Streeter, Frank A. Vicini, Martin Keisch, Melvin A. Astrahan, Gabor Jozsef, Melvin Silverstein, Howard Silberman, Deirdre Cohen, Kristin A. Skinner

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Abstract

The MammoSite®, Radiation Therapy System (RTS) has become the most widely used brachytherapy method used in the treatment of breast cancer, due to its ease of use, short learning curve, and requirement of only one interstitial path through the breast skin. The dosimetry is simple, one source position in the middle of the MammoSite® balloon catheter. The data on long-term complications, however are not available, though developing. Trials for DCIS are being developed, as well as a comparison trial to standard external beam radiation as well as other forms of accelerated partial breast irradiation (APBI).

Original language	English
Pages (from-to)	491-496
Number of pages	6
Journal	Breast
Volume	12
Issue number	6
DOIs	https://doi.org/10.1016/S0960-9776(03)00157-7
State	Published - Dec 2003
Externally published	Yes

Keywords

Brachytherapy
Breast cancer
Breast-conservation therapy (BCT)
Clinical trials
High dose rate
MammoSite® RTS

Access to Document

10.1016/S0960-9776(03)00157-7

Cite this

@article{48a727de803f476989734a811f7b3c2b,

title = "MammoSite{\textregistered} radiation therapy system",

abstract = "The MammoSite{\textregistered}, Radiation Therapy System (RTS) has become the most widely used brachytherapy method used in the treatment of breast cancer, due to its ease of use, short learning curve, and requirement of only one interstitial path through the breast skin. The dosimetry is simple, one source position in the middle of the MammoSite{\textregistered} balloon catheter. The data on long-term complications, however are not available, though developing. Trials for DCIS are being developed, as well as a comparison trial to standard external beam radiation as well as other forms of accelerated partial breast irradiation (APBI).",

keywords = "Brachytherapy, Breast cancer, Breast-conservation therapy (BCT), Clinical trials, High dose rate, MammoSite{\textregistered} RTS",

author = "Streeter, {Oscar E.} and Vicini, {Frank A.} and Martin Keisch and Astrahan, {Melvin A.} and Gabor Jozsef and Melvin Silverstein and Howard Silberman and Deirdre Cohen and Skinner, {Kristin A.}",

year = "2003",

month = dec,

doi = "10.1016/S0960-9776(03)00157-7",

language = "English",

volume = "12",

pages = "491--496",

journal = "Breast",

issn = "0960-9776",

publisher = "Churchill Livingstone",

number = "6",

}

TY - JOUR

T1 - MammoSite® radiation therapy system

AU - Streeter, Oscar E.

AU - Vicini, Frank A.

AU - Keisch, Martin

AU - Astrahan, Melvin A.

AU - Jozsef, Gabor

AU - Silverstein, Melvin

AU - Silberman, Howard

AU - Cohen, Deirdre

AU - Skinner, Kristin A.

PY - 2003/12

Y1 - 2003/12

N2 - The MammoSite®, Radiation Therapy System (RTS) has become the most widely used brachytherapy method used in the treatment of breast cancer, due to its ease of use, short learning curve, and requirement of only one interstitial path through the breast skin. The dosimetry is simple, one source position in the middle of the MammoSite® balloon catheter. The data on long-term complications, however are not available, though developing. Trials for DCIS are being developed, as well as a comparison trial to standard external beam radiation as well as other forms of accelerated partial breast irradiation (APBI).

AB - The MammoSite®, Radiation Therapy System (RTS) has become the most widely used brachytherapy method used in the treatment of breast cancer, due to its ease of use, short learning curve, and requirement of only one interstitial path through the breast skin. The dosimetry is simple, one source position in the middle of the MammoSite® balloon catheter. The data on long-term complications, however are not available, though developing. Trials for DCIS are being developed, as well as a comparison trial to standard external beam radiation as well as other forms of accelerated partial breast irradiation (APBI).

KW - Brachytherapy

KW - Breast cancer

KW - Breast-conservation therapy (BCT)

KW - Clinical trials

KW - High dose rate

KW - MammoSite® RTS

UR - http://www.scopus.com/inward/record.url?scp=0347519220&partnerID=8YFLogxK

U2 - 10.1016/S0960-9776(03)00157-7

DO - 10.1016/S0960-9776(03)00157-7

M3 - Article

C2 - 14659126

AN - SCOPUS:0347519220

SN - 0960-9776

VL - 12

SP - 491

EP - 496

JO - Breast

JF - Breast

IS - 6

ER -

MammoSite® radiation therapy system

Abstract

Keywords

Access to Document

Fingerprint

Cite this